Cargando…

Cushing’s Disease as a Result of Two ACTH-Secreting Pituitary Tumors

OBJECTIVE: Our objective is to present a case of Cushing’s disease (CD) with 2 adrenocorticotropic hormone (ACTH)-secreting pituitary tumors. Multiple monohormonal pituitary tumors are rare. This case supports a consideration of repeat transsphenoidal surgery (TSS) in patients with initial surgical...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathai, Christine, Anolik, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Clinical Endocrinology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053624/
https://www.ncbi.nlm.nih.gov/pubmed/34095475
http://dx.doi.org/10.1016/j.aace.2020.12.002
_version_ 1783680159905218560
author Mathai, Christine
Anolik, Jonathan
author_facet Mathai, Christine
Anolik, Jonathan
author_sort Mathai, Christine
collection PubMed
description OBJECTIVE: Our objective is to present a case of Cushing’s disease (CD) with 2 adrenocorticotropic hormone (ACTH)-secreting pituitary tumors. Multiple monohormonal pituitary tumors are rare. This case supports a consideration of repeat transsphenoidal surgery (TSS) in patients with initial surgical failure. METHODS: Salivary, 24-h urine, serum cortisol testing, and magnetic resonance imaging (MRI) were used to diagnose CD. Treatment included TSS and postoperative hydrocortisone. RESULTS: A 36-year-old woman followed for hypothyroidism presented with a new left supraclavicular fossa swelling and underwent Cushing’s syndrome screening. The levels of late-night salivary cortisol were 0.636 and 0.316 μg/dL, 24-h urine cortisol was 162 μg/24 h, cortisol after 1-mg dexamethasone suppression was 14.0 μg/dL, and serum morning cortisol was 26.4 μg/dL with ACTH of 66.7 pg/mL. A 7-mm hypoenhancing anterior pituitary lesion was noted on pituitary MRI. The cortisol level was 2.7 μg/dL after an 8-mg dexamethasone suppression. She underwent TSS, and her histopathology read as pituitary adenoma staining positive for ACTH. No residual tumor was seen intraoperatively. Postoperative morning serum cortisol was 17.9 μg/dL, and ACTH level was 79 pg/mL. Repeat TSS revealed a second adenoma previously unseen on MRI, which also stained positive for ACTH. Postoperative morning cortisol was 0.7 μg/dL, and ACTH was <9 pg/mL. Hydrocortisone, which was started for her central adrenal insufficiency, was tapered and stopped 1 year postoperatively. Late-night salivary cortisol levels were 0.016 and 0.012 μg/dL. CONCLUSION: We conclude that surgical failure in CD after initial TSS should warrant the consideration of a second ACTH-secreting pituitary adenoma and possible repeat TSS.
format Online
Article
Text
id pubmed-8053624
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Association of Clinical Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-80536242021-06-03 Cushing’s Disease as a Result of Two ACTH-Secreting Pituitary Tumors Mathai, Christine Anolik, Jonathan AACE Clin Case Rep Case Report OBJECTIVE: Our objective is to present a case of Cushing’s disease (CD) with 2 adrenocorticotropic hormone (ACTH)-secreting pituitary tumors. Multiple monohormonal pituitary tumors are rare. This case supports a consideration of repeat transsphenoidal surgery (TSS) in patients with initial surgical failure. METHODS: Salivary, 24-h urine, serum cortisol testing, and magnetic resonance imaging (MRI) were used to diagnose CD. Treatment included TSS and postoperative hydrocortisone. RESULTS: A 36-year-old woman followed for hypothyroidism presented with a new left supraclavicular fossa swelling and underwent Cushing’s syndrome screening. The levels of late-night salivary cortisol were 0.636 and 0.316 μg/dL, 24-h urine cortisol was 162 μg/24 h, cortisol after 1-mg dexamethasone suppression was 14.0 μg/dL, and serum morning cortisol was 26.4 μg/dL with ACTH of 66.7 pg/mL. A 7-mm hypoenhancing anterior pituitary lesion was noted on pituitary MRI. The cortisol level was 2.7 μg/dL after an 8-mg dexamethasone suppression. She underwent TSS, and her histopathology read as pituitary adenoma staining positive for ACTH. No residual tumor was seen intraoperatively. Postoperative morning serum cortisol was 17.9 μg/dL, and ACTH level was 79 pg/mL. Repeat TSS revealed a second adenoma previously unseen on MRI, which also stained positive for ACTH. Postoperative morning cortisol was 0.7 μg/dL, and ACTH was <9 pg/mL. Hydrocortisone, which was started for her central adrenal insufficiency, was tapered and stopped 1 year postoperatively. Late-night salivary cortisol levels were 0.016 and 0.012 μg/dL. CONCLUSION: We conclude that surgical failure in CD after initial TSS should warrant the consideration of a second ACTH-secreting pituitary adenoma and possible repeat TSS. American Association of Clinical Endocrinology 2020-12-28 /pmc/articles/PMC8053624/ /pubmed/34095475 http://dx.doi.org/10.1016/j.aace.2020.12.002 Text en © 2020 AACE. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Mathai, Christine
Anolik, Jonathan
Cushing’s Disease as a Result of Two ACTH-Secreting Pituitary Tumors
title Cushing’s Disease as a Result of Two ACTH-Secreting Pituitary Tumors
title_full Cushing’s Disease as a Result of Two ACTH-Secreting Pituitary Tumors
title_fullStr Cushing’s Disease as a Result of Two ACTH-Secreting Pituitary Tumors
title_full_unstemmed Cushing’s Disease as a Result of Two ACTH-Secreting Pituitary Tumors
title_short Cushing’s Disease as a Result of Two ACTH-Secreting Pituitary Tumors
title_sort cushing’s disease as a result of two acth-secreting pituitary tumors
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053624/
https://www.ncbi.nlm.nih.gov/pubmed/34095475
http://dx.doi.org/10.1016/j.aace.2020.12.002
work_keys_str_mv AT mathaichristine cushingsdiseaseasaresultoftwoacthsecretingpituitarytumors
AT anolikjonathan cushingsdiseaseasaresultoftwoacthsecretingpituitarytumors